Skip to main navigation
  • About
    • Leadership
    • Board of Directors
    • Pharmaceutical Partnerships
    • Meet F-Star Team Members
  • Technology
    • Our Platform
    • Publications
    • Intellectual Property
  • Pipeline
    • FS118
    • FS120
    • FS222
    • SB 11285
    • Partnerships
  • Investors
  • Careers
  • News
  • Contact Us
F-star Therapeutics
  • Careers
  • Investors
  • About
    • Leadership
    • Board of Directors
    • Pharmaceutical Partnerships
    • Meet F-Star Team Members
  • Technology
    • Our Platform
    • Publications
    • Intellectual Property
  • Pipeline
    • FS118
    • FS120
    • FS222
    • SB 11285
  • Contact

Press Releases

  • Overview
  • Press Releases
  • Events & Presentations
  • Stock Information
  • SEC Filings
  • Analyst Coverage
  • Annual Shareholder Meeting
  • Governance
  • IR Resources
  • Navigate
      • Overview
      • Press Releases
      • Events & Presentations
      • Stock Information
      • SEC Filings
      • Analyst Coverage
      • Annual Shareholder Meeting
      • Governance
      • IR Resources
  • Sep 15, 2017

    F-star Wins “UK Life Sciences Deal of the Year” and “UK Life Sciences CEO of the Year” at the Biotech and Money 2017 Awards
  • Jun 22, 2017

    F-star Finalist in Three Categories of 2017 Biotech and Money Awards
  • Jun 04, 2017

    F-star Expands its Relationship with Merck through a new Strategic Collaboration to Develop Bispecific Antibodies in Immuno-Oncology
  • Apr 27, 2017

    Bristol-Myers Squibb Decides not to Exercise its Option to Acquire F-star Alpha
  • Apr 05, 2017

    F-star Presents Preclinical Data at AACR 2017 on Tumour Growth Inhibition in Colon Carcinoma Models using Bispecific Antibodies
  • Mar 24, 2017

    F-star Awarded “Life Science Innovation” Company of the Year by Business Weekly

Pagination

  • Previous page < Previous
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Current page 9
  • Investor Contact
  • RSS
  • Print Page

About

  • Overview
  • Leadership
  • Board of Directors
  • Pharmaceutical Partnerships

Technology

  • Overview
  • Our Platform
  • Publications
  • Intellectual Property

Pipeline

  • Program Overview
  • FS118
  • FS120
  • FS222
  • SB 11285

 

  • Investors
  • Careers
  • News
  • Contact Us
  • About
    • Leadership
    • Board of Directors
    • Pharmaceutical Partnerships
    • Meet F-Star Team Members
  • Technology
    • Our Platform
    • Publications
    • Intellectual Property
  • Pipeline
    • FS118
    • FS120
    • FS222
    • SB 11285
    • Partnerships
  • Investors
  • Careers
  • News
  • Contact Us
  • LinkedIn
  • Twitter

Eddeva B920
Babraham Research
CampusCambridge, CB22 3AT, UK

245 First Street
Riverview II, Floor 18
Cambridge, MA 02142, USA

  • Disclaimer
  • Privacy Policy
  • Cookie Policy
  • Careers
  • Sitemap

© 2023 F-star Therapeutics, Inc.